Loyalty Corporation transfers 40% of Luz Health to Macquarie for a €310 million deal
In a significant move for the Portuguese healthcare sector, the Insurer Luz Saúde, owned by Fosun, has sold a 40% stake to the Macquarie Group's fund. This development was reported by Miguel Prado, the Economics Editor at a leading news outlet.
Miguel Prado, who is involved in reporting on economic matters, highlighted that Luz Saúde, prior to the sale, generated over 700 million euros in revenue last year. The sale of a 40% stake in Luz Saúde was made to the Macquarie group's fund, but the exact name of the fund is not specified in the available information.
Despite the sale, Fidelidade, the parent company, will continue to own nearly 60% of Luz Saúde. This means that Fidelidade's control over the company remains unchanged. The sale did not affect Luz Saúde's financial performance, as it continues to be a profitable venture.
It is important to note that Miguel Prado is not directly associated with Fosun, the previous owner of a portion of Luz Saúde. The Macquarie group's fund, on the other hand, is the new stakeholder in Luz Saúde.
Luz Saúde, a key figure in this news article, generated over 700 million euros in revenue last year. The company's significant financial standing and growth potential made it an attractive investment for the Macquarie group's fund.
The Macquarie Group, a global financial services provider, is known for its diverse portfolio and strategic investments. This move by the Macquarie Group's fund into the Portuguese healthcare sector is a testament to the sector's promising future.
In conclusion, the sale of a 40% stake in Luz Saúde to the Macquarie group's fund marks a significant development in the Portuguese healthcare sector. Despite the change in stakeholders, Fidelidade will continue to hold a majority stake in Luz Saúde, ensuring its continued growth and success.
